Osteonecrosis in a Chemically Induced Rat Model of Human Hemolytic Disorders Associated with Thrombosis - A New Model for Avascular Necrosis of Bone

Calcified Tissue International

Volumn 74, Issue 3, 2004, Pages 220-228

  Shabat, S ^a   Nyska, A ^b   Long, P H ^c   Goelman, G ^d   Abramovitch, R ^d   Ezov, N ^e   Levin Harrus, T ^e   Peddada, S ^b   Redlich, M ^f   Yedgar, S ^g   Nyska, M ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c Pathol Assoc A Charles River Co   (United States)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e Harlan Biotech Israel Limited   (Israel)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^g HEBREW UNIVERSITY   (Israel)

Author keywords

2 Butoxyethanol; MRI; Osteonecrosis; Rat; Thrombosis

Indexed keywords

2 BUTOXYETHANOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AVASCULAR NECROSIS; BONE DENSITY; CONFERENCE PAPER; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; FAT NECROSIS; FEMALE; FIBROUS DYSPLASIA; GRANULOMATOUS INFLAMMATION; GROWTH PLATE; HEMOLYTIC ANEMIA; INFARCTION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; RAT; THROMBOSIS; TRABECULAR BONE;

ANIMALS; DISEASE MODELS, ANIMAL; ETHYLENE GLYCOLS; FEMALE; HEMOLYSIS; MAGNETIC RESONANCE IMAGING; MALE; OSTEONECROSIS; RATS; RATS, INBRED F344; SEX FACTORS; SOLVENTS; SPINE; TAIL; THROMBOSIS;

EID: 12144287779     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-003-0068-7     Document Type: Conference Paper

References (51)

1. Barker JE, Wandersee NJ (1999) Thrombosis in heritable hemolytic disorders. Curr Opin Hematol 6:71-75
2. Borgna Pignatti C, Carnelli V, Caruso V, Dore F, et al. (1999) Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 99:76-79
3. Eldor A, Durst R, Hy-Am E, et al. (1999) A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol 107:739-746
4. Eldor A, Maclouf J, Lellouche F, Ben-Yashar V, Barenholz Y, Durst R, Hy-Am E, Goldfarb A, Rachmilewitz E (1993) A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Southeast Asian J Trop Med Public Health 24(suppl 1):92-95
5. Logothetis J, Constantoulakis M, Economidou J, Stefanis C, Hakas P, Augoustaki O, Sofroniadou K, Loewenson R, Bilek M (1972) Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 22:294-304
6. Garza JA (1990) Massive fat and necrotic bone marrow embolization in a previously undiagnosed patient with sickle cell disease. Am J Forensic Med Pathol 11:83-88
7. Glueck CJ, Crawford A, Roy D (1996) Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am 78:3-13
8. Glueck CJ, Freiberg R, Glueck HI (1994) Gypofibrinolusis: a common major cause of osteonecrosis. Am J Hematol 45:156-166
9. Kim SK, Miller JH (2002) Natural history and distribution of bone and bone marrow infarction in sickle cell hemoglobinopathies. J Nucl Med 43:896-900
10. Milner PF, Brown M (1982) Bone marrow infarction in sickle cell anemia: correlation with hematologic profiles. Blood 60:586-589
11. Nyska A, Maronpot RR, Long PH, Hailey RJ, Travlos GS, Roycroft JH, Ghanayem BI (1999) Disseminated thrombosis and bone infarction in female rats following inhalation exposure to 2-butoxyethanol. Toxicol Pathol 27:287-294
12. Rothschild BM, Sebes JI, Hershkovitz I (1997) Microfoci of avascular necrosis in sickle cell anemia: pathophysiology of the dot dash pattern. Clin Exp Rheumatol 15:663-666
13. Ezov N, Levin-Harrus T, Mittelman M, Redlich M, Shabat S, Ward SM, Peddada S, Nyska M, Yedgar S, Nyska A (2002) Chemically induced rat model of hemolysis with disseminated thrombosis. Cardiovasc Toxicol 2:181-193
14. Ghanayem BI (1989) Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro. Biochem Pharmacol 38:1679-1684
15. Ghanayem BI (1996) An overview of the hematotoxicity of ethylene glycol ethers. Occup Med 2:253-268
16. Ghanayem BI, Blair PC, Thompson HB, Maronpot RR, Matthews HB (1987) Effect of age on the toxicity and metabolism of ethylene glycol monobutyl ether (2-butoxyethanol) in rats. Toxicol Appl Pharmacol 91:222-234
17. Ghanayem BI, Long PH, Ward SM, Chanas B, Nyska M, Nyska A (2001) Hemolytic anemia, thrombosis, and infarction in male and female F344 rats following gavage exposure to 2-butoxyethanol. Exp Toxicol Pathol 53:97-105
18. Ghanayem BI, Ward SM, Chanas B, Nyska A (2000) Comparison of the acute hemotoxicity of 2-butoxyethanol in male and female F344 rats. Hum Exp Toxicol 19:185-192
19. Ghanayem BI, Burka LT, Matthews HB (1987) Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases. J Pharmacol Exp Ther 242:222-231
20. Ghanayem BI, Sullivan CA (1993) Assessment of the hemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans. Hum Exp Toxicol 12:305-311
21. Long PH, Maronpot RR, Ghanayem BI, Roycroft JH, Nyska A (2000) Dental pulp infarction in female rats following inhalation exposure to 2-butoxyethanol. Toxicol Pathol 28:246-252
22. National Toxicology Program (1998) Toxicology and carcinogenesis studies of 2-butoxyethanol (CAS No. 111-76-2) in F344/N rats and B6C3F1 mice (inhalation studies) 1998 Technical Report Series 484, Department of Health and Human Services, Public Health Service, Bethesda, Maryland
23. Nyska A, Maronpot RR, Ghanayem BI (1999) Ocular thrombosis and retinal degeneration induced in female F344 rats by 2-butoxyethanol. Hum Exp Toxicol 18:577-582
24. Jaramillo D, Hoffer FA (1992) Abnormalities of the cartilaginous epiphysis and growth plate: MR demonstration. AJR 158:1105-1110
25. Jaramillo D, Hoffer FA, Shapiro F, Rand F (1990) MR imaging of fractures of the growth plate. AJR 155:1261-1265
26. Jaramillo D, Laor T, Mulkern RV (1994) Comparison between fast spin-echo and conventional spin-echo imaging of normal and abnormal musculoskeletal structures in children and young adults. Invest Radiol 29:803-811
27. Jaramillo D, Shapiro F, Hoffer FA, Winalski CS, Koskinen MF, Frasso R, Johnson A (1990) Post-traumatic growth-plate abnormalities: MR imaging of bony-bridge formation in rabbits. Radiology 175:767-773
28. In: Grossblatt N (Ed.) (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC
29. Chhabra RS, Huff JE, Schwetz BS, Selkirk J (1990) An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ Health Perspect 86:313-321
30. Levin S, Bucci TJ, Cohen SM, Fix AS, Hardisty JF, LeGrand EK, Maronpot RR, Trump BF (1999) The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists. Toxicol Pathol 27:484-490
31. Rosenberg AE (1994) Skeletal system and soft tissue tumors. In: Cotran RS, Kumar V, Robbins S (Eds.) Pathologic basis of disease, 5th ed. WB Saunders Company, Philadelphia, pp 1213-1271
32. Mankin HJ (1992) Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326:1473-1479
33. Sugioka Y, Tsutsui H, Hirano K, Sueishi K (1990) Pathological studies of idiopathic and steroid-induced femoral head necrosis. J Jpn Orthop Assoc 64:1387.
34. Sueishi K, Hirano K, Tsutsui H, Sugioka Y (1993) Clinico-pathological examination of avascular necrosis of the femoral heads. Orthop Surg Traumatol 36:3-12
35. Eldor A, Rachmilewitz EA (2002) The hypercoagulable state in thalassemia. Blood 99:36-43
36. Brashear HR (1963) Epiphyseal avascular necrosis and its relation to longitudinal bone growth. J Bone Joint Surg (Am) 45:1423-1438
37. Brody AS, Strong M, Babikian G, Sweet DE, Seidel FG, Kuhn JP (1991) Avascular necrosis: early MR imaging and histologic findings in a canine model. AJR 157:341-345
38. Lang P, Jergesen HE, Genant HK, Moseley ME, Schulte-Monting J (1989) Magnetic resonance imaging of the ischemic femoral head in pigs. Clin Orthop 276:272-280
39. Nakamura T, Matsumoto T, Nishino M, Tomita K, Kadoya M (1997) Early magnetic resonance imaging and histologic findings in a model of femoral head necrosis. Clin Orthop 334:68-72
40. Sakai T, Sugano N, Tsuji T, Miyazawa T, Nakamura N, Haraguchi K, Ochi T, Ohzono K (1999) Contrast-enhanced magnetic resonance imaging in a nontraumatic rabbit osteonecrosis model. J Orthop Res 17:784-792
41. Seiler 3rd JG, Kregor PJ, Conrad 3rd EU, Swiontkowski MF (1996) Posttraumatic osteonecrosis in a swine model. Correlation of blood cell flux, MRI and histology. Acta Orthop Scand 67:249-254
42. Lendinara L, Accorsi C, Agostini C, Angelini G, Baruffaldi F, Fini M, Motta M, Giavaresi G (2001) Proton magnetic relaxation in bone marrow related to age and bone mineral density: low-resolution in vitro studies. Magn Reson Imaging 19:745-753
43. Alavi A, Schumacher HR, Dorwart B, Kuhl DE (1985) Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease. J Pediatr 107:685-688
44. Arnold KE, Char G, Serjeant GR (1993) Portal vein thrombosis in a child with homozygous sickle-cell disease. West Indian Med J 42:27-28
45. Kaysser TM, Wandersee NJ, Bronson RT, Barker JE (1997) Thrombosis and secondary hemochromatosis play major roles in the pathogenesis of jaundiced and spherocytic mice, murine models for hereditary spherocytosis. Blood 90:4610-4619
46. Kinney TR, Sleeper LA, Wang WC, et al. (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 103:640-645
47. Martin CR, Johnson CS, Cobb C, Tatter D, Haywood LJ (1996) Myocardial infarction in sickle cell disease. J Natl Med Assoc 88:428-432
48. Onuba O (1993) Bone disorders in sickle-cell disease. Int Orthop 17:397-399
49. Reed W, Vichinsky EP (1998) New considerations in the treatment of sickle cell disease. Annu Rev Med 49:461-474
50. Slauson DO (2001) Disturbances of blood flow and circulation. In: Slauson DO, Cooper BJ (Eds.) Mechanisms of disease, 3rd ed. Mosby, St. Louis, pp 89-139
51. Wolters HJ, ten Cate H, Thomas LL, Brandjes DP, van der Ende A, van der Heiden Y, Statius van Eps LW (1995) Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment? Br J Haematol 90:715-717